The use of nanotechnology in medical products has been demonstrated at laboratory scale, and many resulting nanomedicines are in the translational towards clinical applications, with global market trends indicating strong growth of the sector in coming years.
The translation of nanomedicines towards the clinic and subsequent commercialisation may requires the development of new or adaptation of existing standards to ensure the quality, safety, and efficacy of such products.
This work addresses some identified needs, and illustrates the shortcomings of currently used standardised methods when applied to medical-nanoparticles to assess particle size, drug loading, drug release and in vitro safety. Alternative physicochemical, and in vitro toxicology methods, with potential to qualify as future standards supporting the evaluation of nanomedicine are provided.
GIORIA Sabrina;
CAPUTO Fanny;
URBAN LOPEZ Patricia;
CIARAN MANUS Maguire;
BREMER Susanne;
PRINA-MELLO Adriele;
CALZOLAI Luigi;
MĖHN Dóra;
2018-05-04
FUTURE MEDICINE LTD
JRC109027
1743-5889,
https://publications.jrc.ec.europa.eu/repository/handle/JRC109027,
10.2217/nnm-2017-0338,
| Name | Country | City | Type |
|---|
This document is only visible at the Commission level.
You are not authorized to publish or distribute it outside the European Commission.
This is a public document. You can share this publication.
Datasets
| ID | Title | Public URL |
|---|
Dataset collections
| ID | Acronym | Title | Public URL |
|---|
Scripts / source codes
| Description | Public URL |
|---|
Additional supporting files
| File name | Description | File type |
|---|